Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 59 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 8927725

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  2. US 8921340

    Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  3. US 8921323

    Methods and compositions for modulating BCL-2 family polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  4. US 8921071

    Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  5. US 8920807

    Vault complexes for cytokine delivery

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  6. US 8921050

    Methods of diagnosing renal cell carcinoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  7. US 8921097

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  8. US 8916596

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  9. US 8916175

    Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  10. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  11. US 8916556

    Pharmaceutical formulations comprising neurotrophin mimetics

    The United States of America represented by the Department of Vetran Affairs · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  12. US 8916570

    A3 adenosine receptor agonists and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  13. US 8916172

    MVA expressing modified HIV envelope, gag, and pol genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  14. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  15. US 8912146

    Derivatives of APF and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  16. US 8911742

    Transcutaneous immunization without heterologous adjuvant

    The United States of America as represented by the Secretary of the Army · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  17. US 8911728

    High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  18. US 8906384

    Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  19. US 8907060

    Mutated Pseudomonas exotoxins with reduced antigenicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  20. US 8906358

    Leishmania challenge model

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  21. US 8900599

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  22. US 8901093

    Custom vectors for treating and preventing pancreatic cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  23. US 8895018

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  24. US 8895521

    Methods and compositions for the treatment of uveitis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.